Impetigo
📧 Sign up to get email alerts when something new happens for Impetigo.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-12-30FDA Approved: MUPIROCIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for mupirocin (generic) from Glenmark Pharmaceuticals Inc., USA, related to an existing ANDA.
-
FDA approval · 2015-11-18FDA Approved: MUPIROCIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA has approved a supplemental application for mupirocin from Sun Pharmaceutical Industries, Inc., signaling an approved change related to …
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Vehicle Controlled Efficacy and Safety Study of Two Dose Regimens of CD07223 1.5% Topical Gel in Impetigo [Phase 2, Phase 3]
Completed vehicle-controlled efficacy and safety study (Phase 2/3) evaluating two dose regimens of CD07223 1.5% topical gel in impetigo.
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of Two Doses of LTX-109 in Impetigo [Phase 2]
A Phase II trial evaluating two doses of LTX-109 for impetigo has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial [Phase 1]
A randomized, double-blind Phase 1 trial comparing 1% topical papaya leaf extract ointment with 2% mupirocin ointment for the treatment of l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients [Phase 2]
Phase 2 study evaluating topical minocycline FXFM244 in impetigo has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: EU PV for Retapamulin-Prescribing
This document reports a completed clinical trial update on retapamulin prescribing in the EU pharmacovigilance program for impetigo.
-
FDA approval · 2013-01-24FDA Approved: MUPIROCIN — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original ANDA for mupirocin topical antibiotic, enabling a generic version to be marketed. The approval confirms the…
-
CLINICAL_TRIALS research · 2012-06-20Clinical Trial Update: Citriodiol® and Impetigo [Phase 2, Phase 3]
This document reports an ongoing Phase 2/Phase 3 trial of Citriodiol® for impetigo, with the trial status not disclosed.
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA [Phase 3]
Phase 3 trial comparing retapamulin to linezolid for staphylococcal skin infections including impetigo; results posted in 2011.
-
FDA approval · 2011-06-08FDA Approved: MUPIROCIN — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's generic mupirocin (ANDA 090480). The approval covers its topical antibiotic use for impetigo and intranasal use …
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Safety and Efficacy of Topical NVC-422 Gel in Impetigo [Phase 2]
Phase 2 trial evaluating the safety and efficacy of topical NVC-422 gel for impetigo has completed enrollment and reported results.
-
FDA approval · 2010-12-20FDA Approved: CEPHALEXIN — Original Application (AvPAK)
FDA approved the original application for Cephalexin (generic) from AvPAK under ANDA090836.
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Fucidin® Cream in the Treatment of Impetigo [Phase 4]
Phase 4 trial of Fucidin Cream for impetigo was terminated; results were posted in 2010.
-
CLINICAL_TRIALS research · 2009-04-21Clinical Trial Update: Evaluation of a Regional Healthy Skin Program in Remote Aboriginal Communities of Australia's Northern Territory
A completed clinical trial evaluating a regional healthy skin program in remote Aboriginal communities of Australia's Northern Territory to …
-
CLINICAL_TRIALS trial_result · 2008-05-02Clinical Trial Update: Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji
An NIAID-sponsored clinical trial in Fiji evaluated the prevalence of Group A Streptococcal pyoderma (impetigo) and scabies in infants. The …